Chapter 182-51 WAC

Last Update: 8/16/22

DRUG PRICE TRANSPARENCY PROGRAM

WAC Sections

HTMLPDF182-51-0050Authority and purpose.
HTMLPDF182-51-0100Definitions.
DATA REPORTING, NOTICES, AND CONFIDENTIALITY
HTMLPDF182-51-0200Reporting entity registration.
HTMLPDF182-51-0300Health carriers—Cost utilization data reporting.
HTMLPDF182-51-0400Pharmacy benefit managers—Data reporting.
HTMLPDF182-51-0500Pharmacy benefit managers—Compliance.
HTMLPDF182-51-0600Manufacturers—Data and price reporting.
HTMLPDF182-51-0700Manufacturers—Notice of new drug applications and biologic license applications.
HTMLPDF182-51-0800Pharmacy services administrative organizations—Data reporting.
HTMLPDF182-51-0900Data confidentiality.
HTMLPDF182-51-1000Data submission guides.
ENFORCEMENT
HTMLPDF182-51-1100Authority to assess fines.
HTMLPDF182-51-1200Extension of deadlines.
HTMLPDF182-51-1300Fines for failure to comply with reporting requirements.
HTMLPDF182-51-1400Amount of fines based on culpability.
HTMLPDF182-51-1500Preliminary notice of violation and fine(s).
HTMLPDF182-51-1600Process to appeal determination of a violation and assessed fines.
HTMLPDF182-51-1700Informal dispute resolution prior to a hearing.
HTMLPDF182-51-1800Administrative hearing (formal appeal) right.